- Emend: Uses, Dosage Side Effects - Drugs. com
Emend is used together with other medications to prevent nausea and vomiting that may be caused by chemotherapy Emend is given ahead of time and will not treat nausea or vomiting that you already have
- EMEND (fosaprepitant dimeglumine) for injection Label
Use of EMEND with strong or moderate CYP3A4 inhibitors (e g , ketoconazole, diltiazem) may increase plasma concentrations of aprepitant and result in an increased risk of adverse reactions
- emend_pi - Merck
EMEND® is a substance P neurokinin 1 (NK1) receptor antagonist EMEND for oral suspension is indicated EMEND has not been studied for treatment of established nausea and vomiting Chronic continuous administration of EMEND is not recommended
- Emend (Aprepitant): Uses, Side Effects, Dosage More - GoodRx
Emend (aprepitant) is a medication that's used to prevent nausea and vomiting caused by certain anti-cancer medications (chemotherapy) It's usually given an hour before your chemotherapy treatment on days 1 through 3
- Aprepitant (Emend oral, Cinvanti, Aponvie): Uses, Side Effects . . . - WebMD
Find patient medical information for Aprepitant (Emend oral, Cinvanti, Aponvie) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Emend Capsules (Aprepitant Capsules): Side Effects, Uses . . . - RxList
Oral administration of EMEND in combination with ondansetron and dexamethasone (EMEND regimen) has been shown to prevent acute and delayed nausea and vomiting associated with HEC including high-dose cisplatin, and nausea and vomiting associated with MEC
- Emend - Uses, Side Effects, Interactions - MedBroadcast. com
Emend: Aprepitant belongs to the class of medications called neurokinin 1 (NK1) antagonists It is used along with medications called 5-HT3 antagonists (such as ondansetron and granisetron) and dexamethasone to prevent nausea and vomiting caused by certain types of chemotherapy
- DailyMed - EMEND- aprepitant capsule EMEND- aprepitant kit
EMEND is contraindicated in patients who are hypersensitive to any component of the product EMEND is a dose-dependent inhibitor of cytochrome P450 isoenzyme 3A4 (CYP3A4)
|